Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Gains from Sales and Divestitures (2025)

Anaptysbio (ANAB) has disclosed Gains from Sales and Divestitures for 1 consecutive years, with $355627.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures changed N/A year-over-year to $355627.0, compared with a TTM value of $355627.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $355627.0, changed N/A over the prior year.
  • Gains from Sales and Divestitures was $355627.0 for Q4 2025 at Anaptysbio.
  • Across five years, Gains from Sales and Divestitures topped out at $355627.0 in Q4 2025 and bottomed at $355627.0 in Q4 2025.